RARA CRAFT DATABASE for FDA Medical Devices
510(k)K241724

FDA DEVICE FACTS

Cytal® Wound Matrix; Cytal® Burn Matrix

Acell, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 11, 2024PRODUCT CODEKGN

Indications for use

Cytal® Wound Matrix (1-, 2-, 3-, and 6-Layer): Cytal Wound Matrix is intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/ grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears), and draining wounds. The device is intended for one-time use. Cytal® Burn Matrix: Cytal Burn Matrix is intended for the management of wounds including: second-degree burns, partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, skin tears), and draining wounds. The device is intended for one-time use. Technological Characteristics Compared to Predicate The proposed UBM subject devices have the same intended use, design, materials, sterility, and fundamental operation as the predicate devices. The proposed change to extend shelf life to three (3) years does not impact the technological characteristics of the devices. The changes do not raise any new questions of safety and/or effectiveness. Summary of Nonclinical and Clinical Testing Performed The following performance testing has been conducted in support of the substantial equivalence determination. The testing utilized well -established methods, including those from FDA consensus standards. All testing was performed on production equivalent devices.

Performance Bench Test Results* Test Conclusion Dimensional Analysis / Stability Meets Acceptance Criteria Hydration Uptake Meets Acceptance Criteria Tensile Strain Meets Acceptance Criteria Suture Retention Strain Meets Acceptance Criteria Suture Retention Strength Meets Acceptance Criteria Delamination Meets Acceptance Criteria Basement Membrane Staining Meets Acceptance Criteria Hydrated Onset Temperature Meets Acceptance Criteria *Not all testing is applicable for all devices.

Sterilization/Cleaning There are no changes in sterility as a result of the proposed changes.

Shelf Life The shelf-life will be extended from 2 years to 3 years. Animal Studies No animal studies were required as appropriate verification of the subject devices was achieved based on the comparison to the predicate devices and from the results of the bench testing and engineering analysis.

Clinical Studies No clinical studies were required as appropriate verification of the subject devices was achieved based on the comparison to the predicate devices and from the results of the bench testing and engineering analysis.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026